Matches in SemOpenAlex for { <https://semopenalex.org/work/W626104297> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W626104297 endingPage "714" @default.
- W626104297 startingPage "708" @default.
- W626104297 abstract "Although the Japanese government is promoting the use of generic drugs in order to reduce medical costs, providing information to physicians and pharmacists on the quality, safety or utility of generic drugs compared to the original drugs is insufficient. Carboplatin is a platinum-containing antineoplastic agent that is used for the treatment of several types of cancer. Carboplatin Intravenous Infusion “NK” (GE-CBDCA) is a generic drug of Paraplatin® Injection (OR-CBDCA). In this study, we investigated the quality and safety of OR-CBDCA and GE-CBDCA. Purity tests conducted using high performance liquid chromatography showed that there were no clear differences between the two drugs with respect to contaminant or related substances. As a result of susceptibility testing performed in vitro by using five types of tumor cells, both drug products showed similar receptivity. For comparison of adverse drug reactions, the incidence of adverse events was surveyed in 72 patients who underwent chemotherapy switched from OR-CBDCA to GE-CBDCA. No significant differences were found in seven of eight parameters. Hematological tests of hemoglobin and white blood cell counts tended to show a higher incidence of more serious adverse reactions in the group treated with GE-CBDCA, and the GE-CBDCA-treated group also showed significant higher neutrophil counts (P = 0.029). However, it was supposed that the total dosage and the administering period of the Carboplatin were factors of the adverse reaction in the GE-CBDCA-treated group, therefore, the quality and safety of the two drug products were considered to be similar." @default.
- W626104297 created "2016-06-24" @default.
- W626104297 creator A5014379692 @default.
- W626104297 creator A5017200303 @default.
- W626104297 creator A5020040975 @default.
- W626104297 creator A5024554124 @default.
- W626104297 creator A5025417798 @default.
- W626104297 creator A5033144930 @default.
- W626104297 creator A5043283404 @default.
- W626104297 creator A5047130261 @default.
- W626104297 creator A5070080018 @default.
- W626104297 creator A5071135489 @default.
- W626104297 creator A5073866661 @default.
- W626104297 creator A5073920519 @default.
- W626104297 creator A5078393057 @default.
- W626104297 creator A5080758164 @default.
- W626104297 date "2012-01-01" @default.
- W626104297 modified "2023-09-30" @default.
- W626104297 title "Examination of Safety in Changing from Paraplatin® for Injection to Carboplatin for Intravenous Infusion “NK^|^quot;" @default.
- W626104297 doi "https://doi.org/10.5649/jjphcs.38.708" @default.
- W626104297 hasPublicationYear "2012" @default.
- W626104297 type Work @default.
- W626104297 sameAs 626104297 @default.
- W626104297 citedByCount "0" @default.
- W626104297 crossrefType "journal-article" @default.
- W626104297 hasAuthorship W626104297A5014379692 @default.
- W626104297 hasAuthorship W626104297A5017200303 @default.
- W626104297 hasAuthorship W626104297A5020040975 @default.
- W626104297 hasAuthorship W626104297A5024554124 @default.
- W626104297 hasAuthorship W626104297A5025417798 @default.
- W626104297 hasAuthorship W626104297A5033144930 @default.
- W626104297 hasAuthorship W626104297A5043283404 @default.
- W626104297 hasAuthorship W626104297A5047130261 @default.
- W626104297 hasAuthorship W626104297A5070080018 @default.
- W626104297 hasAuthorship W626104297A5071135489 @default.
- W626104297 hasAuthorship W626104297A5073866661 @default.
- W626104297 hasAuthorship W626104297A5073920519 @default.
- W626104297 hasAuthorship W626104297A5078393057 @default.
- W626104297 hasAuthorship W626104297A5080758164 @default.
- W626104297 hasBestOaLocation W6261042971 @default.
- W626104297 hasConcept C120665830 @default.
- W626104297 hasConcept C121332964 @default.
- W626104297 hasConcept C126322002 @default.
- W626104297 hasConcept C143998085 @default.
- W626104297 hasConcept C197934379 @default.
- W626104297 hasConcept C2776694085 @default.
- W626104297 hasConcept C2778239845 @default.
- W626104297 hasConcept C2780035454 @default.
- W626104297 hasConcept C2781451048 @default.
- W626104297 hasConcept C61511704 @default.
- W626104297 hasConcept C71924100 @default.
- W626104297 hasConcept C98274493 @default.
- W626104297 hasConceptScore W626104297C120665830 @default.
- W626104297 hasConceptScore W626104297C121332964 @default.
- W626104297 hasConceptScore W626104297C126322002 @default.
- W626104297 hasConceptScore W626104297C143998085 @default.
- W626104297 hasConceptScore W626104297C197934379 @default.
- W626104297 hasConceptScore W626104297C2776694085 @default.
- W626104297 hasConceptScore W626104297C2778239845 @default.
- W626104297 hasConceptScore W626104297C2780035454 @default.
- W626104297 hasConceptScore W626104297C2781451048 @default.
- W626104297 hasConceptScore W626104297C61511704 @default.
- W626104297 hasConceptScore W626104297C71924100 @default.
- W626104297 hasConceptScore W626104297C98274493 @default.
- W626104297 hasIssue "11" @default.
- W626104297 hasLocation W6261042971 @default.
- W626104297 hasOpenAccess W626104297 @default.
- W626104297 hasPrimaryLocation W6261042971 @default.
- W626104297 hasRelatedWork W1481820868 @default.
- W626104297 hasRelatedWork W2053778437 @default.
- W626104297 hasRelatedWork W2060767396 @default.
- W626104297 hasRelatedWork W2072767112 @default.
- W626104297 hasRelatedWork W2076107896 @default.
- W626104297 hasRelatedWork W2105623825 @default.
- W626104297 hasRelatedWork W2349339246 @default.
- W626104297 hasRelatedWork W2471989939 @default.
- W626104297 hasRelatedWork W3013194840 @default.
- W626104297 hasRelatedWork W4296767593 @default.
- W626104297 hasVolume "38" @default.
- W626104297 isParatext "false" @default.
- W626104297 isRetracted "false" @default.
- W626104297 magId "626104297" @default.
- W626104297 workType "article" @default.